Status:
NOT_YET_RECRUITING
Intermittent Fasting for Pancreatitis
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Conditions:
Pancreatitis
Pancreatitis, Acute
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this research is to compare intermittent fasting with a standard diet approach for improving the quality of life related to your pancreas disease. Our hope is to improve your symptoms a...
Detailed Description
Fasting is a classic means for religious discipline, yet recently regaining favor in the medical landscape. Numerous studies have come forth, both in animals and humans outlining the benefit of interm...
Eligibility Criteria
Inclusion
- Age ≥ 18 year
- Recurrent acute pancreatitis defined by greater than 2 episodes of pancreatitis, defined by:
- abdominal pain and either amylase or lipase \> 3 x the upper limit of normal, imaging suggestive of, separated by time
- Anatomy of chronic pancreatitis defined by Rosemont criterion9 or on imaging (CT, MRI)
- Pancreatic exocrine insufficiency defined by a pancreatic elastase \< 200 ug/g stool10
Exclusion
- Age \< 18 years
- Pregnant Patients
- Age \> 80 years
- Patients who cannot consent for themselves
- Glycogen storage disease
- Insulinoma or hypoglycemic state
- Active alcohol abuse
- Alcohol induced acute pancreatitis
- Gallstone induced acute pancreatitis
- Pancreatic solid neoplasm
- Patients with diabetes
- Patients on beta blockers
Key Trial Info
Start Date :
March 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04760847
Start Date
March 1 2026
End Date
April 1 2026
Last Update
April 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moffitt Cancer Center
Tampa, Florida, United States, 33612